Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


PPAR ligand
BML-GR234-0010 10 mg 88.00 USD
BML-GR234-0050 50 mg 353.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-270-356

Potent, selective and irreversible PPARγ antagonist. Blocks the PPARγ-induced differentiation of monocytes to osteoclasts by >90% at a dose of 0.1µM. Much more potent antagonist than BADGE (Prod. No. ALX-270-353). Can be used to antagonize the effects of PPARγ agonists in a variety of cell types.

Product Specification

Alternative Name:2-Chloro-5-nitrobenzanilide
Purity:≥98% (HPLC)
Appearance:White to off-white solid.
Solubility:Soluble in DMSO (50mg/ml), 100% ethanol (10mg/ml) or dimethyl formamide. Insoluble in water.
Long Term Storage:Ambient
Use/Stability:Stable for at least 1 year after receipt when stored at +20°C. Stock solutions are stable for up to 3 months at -20°C.
Technical Info/Product Notes:Note: Product is not sterile.
Please mouse over

Product Literature References

Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation: I. Khuja, et al.; Int. J. Mol. Sci. 20, 668 (2019), Application(s): used to examine CBDs effect on proliferation of CD3 activated murine splenocytes, Abstract; Full Text
Ginsenoside Rb1 promotes browning through regulation of PPARγ in 3T3-L1 adipocytes: Q. Mu, et al.; Biochem. Biophys. Res. Commun. 291, 30581 (2015), Application(s): Antagonize the effects of PPARγ agonists, Abstract;
15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications: T.M. Lindström & P.R. Bennett; J. Clin. Endocrinol. Metab. 90, 3534 (2005), Abstract; Full Text
PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes: A.D. Roth, et al.; J. Neurosci. Res. 72, 425 (2003), Abstract;
Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells: M. Fu, et al.; BBRC 294, 597 (2002), Abstract;
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662: L.M. Leesnitzer, et al.; Biochemistry 41, 6640 (2002), Abstract;
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1: A.C. Bendixen, et al.; PNAS 98, 2443 (2001), Abstract; Full Text
Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3: M. Fu, et al.; J. Biol. Chem. 276, 45888 (2001), Abstract;

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
PPAR Ligand
By catalog section:


Technical Service
Customer Service

Related Literature

Diabetes Catalog
Diabetes Catalog
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,